“…For example, LPS from an E. coli strain containing a null mutation for msbB and lacking the expected secondary myristate on the 3′‐hydroxy‐myristate was found to have 10 000‐fold less ability to induce tumour necrosis factor‐α (TNFα) secretion from blood monocytes and at least 1000‐fold less ability to induce E‐selection upregulation in cultured endothelial cells (Darveau et al ., 1995). Strains of Haemophilus infuenzae , Neisseria meningitidis , Neisseria gonorrhoeae and Salmonella typhimurium containing mutations in htrB and lacking secondary fatty acids on the 2′‐hydroxy‐myristate have also been shown to have reduced inflammatory potential or virulence (Jones et al ., 1997; Vaara and Nurminen, 1999; Ellis et al ., 2001; van der Ley et al ., 2001; Tong et al ., 2001; Post et al ., 2002). Similarly, removal of both secondary fatty acids from purified E. coli LPS by a neutrophil acyloxyacyl hydrolase was shown to have a reduced ability to stimulate neutrophil adherence to endothelial cell layers as well as a reduced ability to promote a dermal Shwartzman reaction (Munford and Hall, 1986; Pohlman et al ., 1987).…”